
Biosimilar Development Simulator
Created for Biopharmaceutical Client
Link copied!

Opening screen demo for Build-a-Biosimlar interactive game showing antibody with biosimilarity score. Users manipulate bioreactor settings, including host cell type, to make a biosimilar that is highly similar in a number of critical quality attributes to a reference biologic. © 2015. All Rights Reserved.

Build a Biosimilars on site at EADV 2015 congress. Users manipulate bioreactor settings, including host cell type, to make a biosimilar that is highly similar in a number of critical quality attributes to a reference biologic. © 2015 Axs Studio, Inc. All Rights Reserved

Build a biosimilar iPad app. User manipulates bioreactor settings, including host cell type, to make a biosimilar that is highly similar in a number of critical quality attributes to a reference biologic. © 2016. All Rights Reserved.
The project
The emergence of biosimilars forced HCPs to navigate questions and misconceptions, including that biosimilars are like generic drugs. The Build a Biosimilar simulator gives participants an appreciation for the difficulty in making a complex biologic molecule highly similar to its reference product. By adjusting manufacturing settings, users see how small changes have significant structural and functional impacts. When finished, participants can initial their own biosimilar and add it to a growing pool of others.
Created for
Biopharmaceutical Client